Trial intelligence / Profile preview

BRN-01 for menopausal hot flushes

2009-016959-21Phase 3Active

Sponsor
Boiron
Start
Jan 2010
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in hot flash comparing BRN-01 with Placebo (2 arms). Primary endpoint: Reduction in hot flush intensity score. Started Jan 2010; status: active.

02

Drugs

Actheane
03

Conditions

hot flash

Beyond the preview

Go deeper on 2009-016959-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-016959-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call